News
Twelve French towns see bans on tap-water drinking over hormone-disrupting PFAS chemicals, as Australia introduces PFAS ban.
Xero’s $2.5B Melio buy aims for US growth, but at the cost of margins. Will it pay off, or repeat past acquisition mistakes? Key risks and analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback